Michaela Ott
Director/Miembro de la Junta en Medite Enterprise, Inc. .
Cargos activos de Michaela Ott
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
Medite Enterprise, Inc.
Medite Enterprise, Inc. Medical SpecialtiesHealth Technology Part of MEDITE Cancer Diagnostics, Inc., Medite Enterprise, Inc. develops diagnostics and therapeutic medical devices. The company is based in Orlando, FL. Michael Egbert Ott has been the CEO of the company since 2013. Medite Enterprise was acquired by CytoCore, Inc. on April 04, 2014 for $342 million. | Director/Miembro de la Junta | 01/01/2013 | - |
Historial de carrera de Michaela Ott
Antiguos cargos conocidos de Michaela Ott.
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
MEDITE CANCER DIAGNOSTICS INC | Director/Miembro de la Junta | 03/04/2014 | 17/01/2018 |
Director Ejecutivo | 03/04/2014 | 26/10/2016 | |
Director de Operaciones | 26/10/2016 | 04/05/2017 | |
Medite GmbH /Austria/
Medite GmbH /Austria/ Medical SpecialtiesHealth Technology Part of MEDITE Cancer Diagnostics, Inc., Medite GmbH is a company based in Salzburg, Austria. Medite GmbH develops diagnostics and therapeutic medical devices. | Director Ejecutivo | - | 30/09/2017 |
MEDITE GmbH
MEDITE GmbH Medical DistributorsDistribution Services Part of MEDITE Cancer Diagnostics, Inc., Medite GmbH is a German company that develops diagnostics and therapeutic medical devices. The company is based in Niedersachsen, Germany. The CEO of the company is Elmar A. Dave. | Presidente | 01/01/2006 | 04/05/2017 |
CytoCore, Inc.
CytoCore, Inc. Medical SpecialtiesHealth Technology CytoCore, Inc. develops, manufactures and sells an integrated family of products for the detection, diagnosis and treatment of cancer. The company markets its products under the trade name CytoCore Solutions, which is intended to address sample collection, specimen preparation, specimen evaluation, including detection/screening and diagnosis, treatment and patient monitoring within vertical markets related to specific cancers. The company also designs, markets and sells a companion product to detect breast cancer. It intends to focus on the expansion of its products for the treatment of gynecological cancer as well as bladder, lung, and breast cancers amongst others. CytoCore was founded in December 1998 and is headquartered in Chicago, IL. | Director Ejecutivo | 03/04/2014 | - |
Estadísticas
Internacional
Estados Unidos | 4 |
Alemania | 2 |
Austria | 2 |
Operativa
Chief Executive Officer | 3 |
Director/Board Member | 2 |
President | 1 |
Sectorial
Health Technology | 5 |
Distribution Services | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
Empresas cotizadas | 1 |
---|---|
MEDITE CANCER DIAGNOSTICS INC | Health Technology |
Empresas privadas | 4 |
---|---|
CytoCore, Inc.
CytoCore, Inc. Medical SpecialtiesHealth Technology CytoCore, Inc. develops, manufactures and sells an integrated family of products for the detection, diagnosis and treatment of cancer. The company markets its products under the trade name CytoCore Solutions, which is intended to address sample collection, specimen preparation, specimen evaluation, including detection/screening and diagnosis, treatment and patient monitoring within vertical markets related to specific cancers. The company also designs, markets and sells a companion product to detect breast cancer. It intends to focus on the expansion of its products for the treatment of gynecological cancer as well as bladder, lung, and breast cancers amongst others. CytoCore was founded in December 1998 and is headquartered in Chicago, IL. | Health Technology |
MEDITE GmbH
MEDITE GmbH Medical DistributorsDistribution Services Part of MEDITE Cancer Diagnostics, Inc., Medite GmbH is a German company that develops diagnostics and therapeutic medical devices. The company is based in Niedersachsen, Germany. The CEO of the company is Elmar A. Dave. | Distribution Services |
Medite Enterprise, Inc.
Medite Enterprise, Inc. Medical SpecialtiesHealth Technology Part of MEDITE Cancer Diagnostics, Inc., Medite Enterprise, Inc. develops diagnostics and therapeutic medical devices. The company is based in Orlando, FL. Michael Egbert Ott has been the CEO of the company since 2013. Medite Enterprise was acquired by CytoCore, Inc. on April 04, 2014 for $342 million. | Health Technology |
Medite GmbH /Austria/
Medite GmbH /Austria/ Medical SpecialtiesHealth Technology Part of MEDITE Cancer Diagnostics, Inc., Medite GmbH is a company based in Salzburg, Austria. Medite GmbH develops diagnostics and therapeutic medical devices. | Health Technology |
- Bolsa de valores
- Insiders
- Michaela Ott
- Experiencia